|
[http://www.aframnews.com/html/includes/left_nav_1.htm]
|
Tobacco Regulation Legislation Tramples
Commercial Free Speech
American Conservative Union
In Washington, there is never a shortage of ideas on new regulations that
someone would like to impose on the American people or American commerce.
One such proposal now pending in Congress is a plan to have the Food and
Drug Administration regulate all tobacco products. As the New York Times
reported last week, proponents, led by Tom Davis (R-VA) and Henry Waxman
(D-CA) in the House, and Mike DeWine (R-OH) and Ted Kennedy (D-MA) in the
Senat,e are pushing for legislation that would “let the Food and Drug
Administration regulate tobacco as a drug.”
The tobacco regulation movement is gathering steam, and that shouldn’t
surprise anyone. After all, tobacco is often considered an easy political
target. But there is one major problem with tobacco regulation legislation
now under consideration. It runs afoul of a cornerstone of American
democracy: The First Amendment right of free speech.
When most Americans think of “free speech” they think of the right to tell
people their views on political candidates or the right to author a
newspaper column such as this. But another important aspect of
Constitutionally-guaranteed free speech is the right of companies to make
statements about their products through advertising or other means, so long
as those statements are truthful. Such statements are generally known as
“commercial free speech,” and the tobacco regulation bill now before
Congress snubs its nose at those rights.
One section of the pending legislation would effectively prohibit a tobacco
company or tobacco distributor from communicating truthful information about
the relative risks of tobacco products. Indeed, this type of communication
by distributors is directly and specifically prohibited by the bill. In the
case of tobacco companies, conveying risk information that isn’t approved by
the FDA would be a violation of the new law. Conveniently, this section of
the bill ignores the fact that the First Amendment does not permit the
government to declare a subject that is of scientific and public policy
interest to tobacco companies and distributors to be off limits to public
discussion.
Recent court decisions have held that the FDA can’t prohibit truthful,
non-misleading product claims on policy grounds. But provisions of the
pending legislation would do just that.
Even though this legislation is problematic from a Constitutional
perspective, it shouldn’t surprise anyone that such language has found its
way into the bill. After all, some of the leading proponents are
organizations such as the Campaign for Tobacco-Free Kids, the American Heart
Association and the American Cancer Society which have long championed
restrictions on what tobacco companies could say about themselves.
Fortunately, the anti-tobacco campaigners don’t trump the First Amendment.
The on-going debate of how best to educate Americans about tobacco is a
legitimate one. But for that debate to go forward in a reasonable and fair
manner, the right of all parties to speak the truth must be preserved.
Fortunately, the First Amendment is on the side of preserving that right.
Free speech – either political or commercial – is a bedrock principle not
only of American law but also of America’s character and culture. It always
has been, and must remain so. The tobacco regulation bill now before
Congress is inconsistent with that principle and should be rejected.
Stacie Rumenap is Deputy Director of the American Conservative Union, the
nation’s oldest and largest conservative grassroots organization.
|